{
  "abstract": "The cardiovascular benefits of weight loss drug semaglutide (Ozempic, Wegovy) occur regardless of how much weight a person loses or their starting body weight, new analysis suggests.1",
  "authors": [
    {
      "affiliations": [
        "Kent"
      ],
      "name": "Jacqui Wise"
    }
  ],
  "title": "Weight loss drugs: Semaglutide boosts heart health regardless of how much weight patients lose, study suggests",
  "uid": "0e50b72b-2f65-5dbf-b601-ee9be1f9d2ce"
}